Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary(®)): Results of a Nationwide Dose Conversion Survey

BACKGROUND: The introduction of carbidopa-levodopa extended-release (CD-LD ER) capsules (Rytary®) did not go as smoothly as expected, largely due to difficulty around dose conversion from available immediate-release (IR) levodopa (LD) formulations. The dose conversion table in the CD-LD ER prescribi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Parkinsons Dis
Autori principali: Hauser, Robert A., Banisadr, Ghazal, Vuong, Kara, Freilich, David, Fisher, Stanley, D'Souza, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914099/
https://ncbi.nlm.nih.gov/pubmed/33688424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6638088
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi